BIOQ (Bioqual) Beginning Cash Position: $18.90 Mil (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOQ Bioqual Inc BIOQ
54 GF Score
Price $33.00
! 4 Warning Signs
View Full Analysis

What is Bioqual Beginning Cash Position?

Bioqual BIOQ 54 Beginning Cash Position is $18.90 Mil as of Nov. 2025. GuruFocus rates BIOQ with a GF Score™ of 54/100. The stock has 4 warning signs investors should review.

Bioqual's Beginning Cash Position for the quarter that ended in Nov. 2025 was $18.90 Mil.

Bioqual's quarterly Beginning Cash Position increased from Nov. 2024 ($14.03 Mil) to Aug. 2025 ($17.85 Mil) and increased from Aug. 2025 ($17.85 Mil) to Nov. 2025 ($18.90 Mil).

Bioqual's annual Beginning Cash Position increased from May. 2011 ($3.15 Mil) to May. 2017 ($5.18 Mil) and increased from May. 2017 ($5.18 Mil) to May. 2018 ($9.29 Mil).

Bioqual Beginning Cash Position Related Terms

Bioqual Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Bioqual's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioqual Beginning Cash Position Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 2.92 3.15 5.18 9.29

Bioqual Quarterly Data
Aug06 Nov06 Feb07 May07 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 May17 May18 Aug22 Aug23 Aug24 Nov24 Aug25 Nov25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.28 15.60 14.03 17.85 18.90
BIOQ
54GF Score
Bioqual Inc BIOQ
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioqual Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $18.90 Mil mean?
Bioqual (BIOQ) has a Beginning Cash Position of $18.90 Mil as of Nov. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Bioqual and its competitors.
Is Bioqual's Beginning Cash Position too high?
Bioqual's current Beginning Cash Position is $18.90 Mil. Overall, Bioqual has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Bioqual's Beginning Cash Position compare to ADVB and QUCY?
Bioqual's Beginning Cash Position of $18.90 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Bioqual and its competitors. Bioqual's current Beginning Cash Position is $18.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioqual stock overvalued right now?
Bioqual (BIOQ) has a current Beginning Cash Position of $18.90 Mil. The current Beginning Cash Position is $18.90 Mil. Bioqual's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Bioqual (BIOQ), the current Beginning Cash Position is $18.90 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioqual Business Description

Address 9620 Medical Center Drive, Suite 310, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
54GF Score

Get the complete analysis for BIOQ

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.00
Price